These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 28477732

  • 1. Focus on growth hormone deficiency and bone in adults.
    Tritos NA.
    Best Pract Res Clin Endocrinol Metab; 2017 Feb; 31(1):49-57. PubMed ID: 28477732
    [Abstract] [Full Text] [Related]

  • 2. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.
    Götherström G, Bengtsson BA, Bosaeus I, Johannsson G, Svensson J.
    Eur J Endocrinol; 2007 Jan; 156(1):55-64. PubMed ID: 17218726
    [Abstract] [Full Text] [Related]

  • 3. Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with growth hormone deficiency (GHD): the Leiden Cohort Study.
    Appelman-Dijkstra NM, Claessen KM, Hamdy NA, Pereira AM, Biermasz NR.
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):727-35. PubMed ID: 24816144
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Growth hormone and bone health.
    Bex M, Bouillon R.
    Horm Res; 2003 Nov; 60 Suppl 3():80-6. PubMed ID: 14671403
    [Abstract] [Full Text] [Related]

  • 9. A densitometric and morphometric analysis of the skeleton in adults with varying degrees of growth hormone deficiency.
    Murray RD, Adams JE, Shalet SM.
    J Clin Endocrinol Metab; 2006 Feb; 91(2):432-8. PubMed ID: 16278268
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Growth hormone deficiency, its influence on bone mineral density and risk of osteoporotic fractures].
    Kuzma M, Payer J.
    Cas Lek Cesk; 2010 Feb; 149(5):211-6. PubMed ID: 20629339
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
    Biermasz NR, Hamdy NA, Janssen YJ, Roelfsema F.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
    [Abstract] [Full Text] [Related]

  • 17. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.
    Johannsson G, Sunnerhagen KS, Svensson J.
    Clin Endocrinol (Oxf); 2004 May; 60(5):550-9. PubMed ID: 15104557
    [Abstract] [Full Text] [Related]

  • 18. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency.
    Boot AM, Engels MA, Boerma GJ, Krenning EP, De Muinck Keizer-Schrama SM.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2423-8. PubMed ID: 9253311
    [Abstract] [Full Text] [Related]

  • 19. Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency.
    Elbornsson M, Götherström G, Bosæus I, Bengtsson BÅ, Johannsson G, Svensson J.
    Eur J Endocrinol; 2012 May; 166(5):787-95. PubMed ID: 22318746
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.